PMID- 30918133 OWN - NLM STAT- MEDLINE DCOM- 20191211 LR - 20191217 IS - 1347-5215 (Electronic) IS - 0918-6158 (Linking) VI - 42 IP - 6 DP - 2019 Jun 1 TI - Ultravist Induces the Expression of MCP-1 and VCAM-1 in IL-4-Stimulated HUVECs. PG - 915-922 LID - 10.1248/bpb.b18-00883 [doi] AB - The goal of the present study focused on the adverse reaction of contrast medium (CM) via the induction of inflammatory molecules in human umbilical vein endothelial cells (HUVECs). Ultravist-induced monocyte chemoattractant protein-1 (MCP-1) and vascular cell adhesion molecule-1 (VCAM-1) gene expression was markedly increased in interleukin-4 (IL-4)-pretreated HUVECs in a time- and dose-dependent manner and was paralleled by concomitant production of MCP-1 and VCAM-1 proteins. MCP-1 and VCAM-1 gene expression by Ultravist in combination with IL-4 was mediated by the c-Jun N-terminal kinases (JNK1/2) signaling pathway. IL-4-pretreated Ultravist-stimulated HUVECs showed greatly increased migration and adhesion of THP-1 cells. Cell migration was decreased by treatment of CCR2 antagonist, and cell adhesion was also decreased by VCAM-1 blocking antibody. Furthermore, when tested in vivo under similar conditions, MCP-1 protein was significantly increased in Ultravist combined with IL-4-injected mice. Taken together, our findings suggest that MCP-1 blocking may be crucial in preventing the endothelial dysfunction induced by contrast medium in patients with inflammatory disease and atherosclerosis. FAU - Kim, Hye-Lim AU - Kim HL AD - Advanced Research Center for Multiple Myeloma, College of Medicine, Inje University. FAU - Kim, Nam-Soo AU - Kim NS AD - Department of Oral and Maxillofacial Surgery, Busan Paik Hospital, Inje University. FAU - Cho, Hae-Yun AU - Cho HY AD - Advanced Research Center for Multiple Myeloma, College of Medicine, Inje University. FAU - Park, Sang-Jun AU - Park SJ AD - Department of Oral and Maxillofacial Surgery, Busan Paik Hospital, Inje University. FAU - Lee, Chae Kwan AU - Lee CK AD - Department of Convergence Biomedical Science, College of Medicine, Inje University. AD - Department of Occupational and Environmental Medicine, College of Medical & Institute of Environmental and Occupational Medicine, Inje University. FAU - Choi, Inhak AU - Choi I AD - Advanced Research Center for Multiple Myeloma, College of Medicine, Inje University. AD - Department of Microbiology and Immunology, Inje University College of Medicine. FAU - Lee, Soo-Woong AU - Lee SW AD - Advanced Research Center for Multiple Myeloma, College of Medicine, Inje University. AD - Department of Convergence Biomedical Science, College of Medicine, Inje University. LA - eng PT - Journal Article DEP - 20190328 PL - Japan TA - Biol Pharm Bull JT - Biological & pharmaceutical bulletin JID - 9311984 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Contrast Media) RN - 0 (STAT1 Transcription Factor) RN - 0 (STAT1 protein, human) RN - 0 (Vascular Cell Adhesion Molecule-1) RN - 207137-56-2 (Interleukin-4) RN - 4419T9MX03 (Iohexol) RN - 712BAC33MZ (iopromide) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) SB - IM MH - Animals MH - Cell Adhesion/drug effects MH - Cell Movement/drug effects MH - Cells, Cultured MH - Chemokine CCL2/*biosynthesis/metabolism MH - Contrast Media MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Female MH - Human Umbilical Vein Endothelial Cells/*drug effects/metabolism MH - Humans MH - Interleukin-4/*pharmacology MH - Iohexol/*analogs & derivatives/pharmacology MH - MAP Kinase Signaling System/drug effects MH - Mice MH - Mice, Inbred C57BL MH - Proto-Oncogene Proteins c-akt/metabolism MH - STAT1 Transcription Factor/metabolism MH - Signal Transduction MH - THP-1 Cells MH - Vascular Cell Adhesion Molecule-1/*biosynthesis/metabolism OTO - NOTNLM OT - cell migration OT - human umbilical vein endothelial cell (HUVEC) OT - interleukin-4 (IL-4) OT - monocyte chemoattractant protein-1 (MCP-1) OT - ultravist EDAT- 2019/03/29 06:00 MHDA- 2019/12/18 06:00 CRDT- 2019/03/29 06:00 PHST- 2019/03/29 06:00 [pubmed] PHST- 2019/12/18 06:00 [medline] PHST- 2019/03/29 06:00 [entrez] AID - 10.1248/bpb.b18-00883 [doi] PST - ppublish SO - Biol Pharm Bull. 2019 Jun 1;42(6):915-922. doi: 10.1248/bpb.b18-00883. Epub 2019 Mar 28.